ArticleHaematologica2012

Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance.

Oliver HantschelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.